Abstract
The 39th annual San Antonio Breast Cancer Symposium (SABCS) was convened in San Antonio, Texas, on 9-13 December 2016. More than 7000 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, locoregional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with Part 1 focusing onmetastatic breast cancer, extended endocrine therapy and the prognostic significance of BRCA1/2 gene mutations. The second part of this report will discuss a range of topics including anti-HER2 directed treatments, the impact of radiotherapy on implant and autologous flap based reconstruction, biological risk predictors for ductal carcinoma-in situ (DCIS), longer term effects of dietary fat modification and the influence of aromatase inhibitors on endothelial cell function.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1291-1295 |
| Number of pages | 5 |
| Journal | Future Oncology |
| Volume | 13 |
| Issue number | 15 |
| DOIs | |
| State | Published - Jun 2017 |
| Externally published | Yes |
Keywords
- Breast conserving surgery
- San Antonio
- extended endocrine
- mastectomy
- radiation treatment
- reconstruction
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Highlights of the San Antonio Breast Cancer Symposium 2016'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS